These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16974186)

  • 21. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of agitation in bipolar disorder across the life cycle.
    Alderfer BS; Allen MH
    J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.
    Levisohn PM; Holland KD
    Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia and valproate.
    Citrome L
    Psychopharmacol Bull; 2003; 37 Suppl 2():74-88. PubMed ID: 15021863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of anticonvulsants in the treatment of impulsive aggression.
    Stanford MS; Helfritz LE; Conklin SM; Villemarette-Pittman NR; Greve KW; Adams D; Houston RJ
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):72-7. PubMed ID: 15727506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
    J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
    Glick ID; Bosch J; Casey DE
    J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study.
    Lykouras L; Hatzimanolis J
    Curr Med Res Opin; 2004 Jun; 20(6):843-7. PubMed ID: 15200741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG; Schreiner A; Peters S; Rettig K; Degner D; Rüther E
    Fortschr Neurol Psychiatr; 2003 May; 71(5):249-54. PubMed ID: 12740756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
    Afshari D; Rafizadeh S; Rezaei M
    Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.